P2176
P3781
BAY88-8223, Alpharadin, Breast Cancer Patients With Bone Dominant DiseaseMetabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 TherapyA Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review StudyTreatment Satisfaction With Ra-223 in JapanStudy of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast CancerStudy of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast CancerNon-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in GermanyDescriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone TherapDrug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone MetastasesProBio: A Biomarker Driven Study in Patients With Metastatic Castrate Resistant Prostate CancerRadium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to BonePRECISE, a Study to Gather More Information About Bone Fractures and Survival in Castration-resistant PRostate Cancer (CRPC) patiEnts Treated With Radium-223 in Routine Clinical practIce in SwedEnStudy to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body
P4844
Q61938800-84F6CCC7-357F-4786-AB0E-4B3BAB610D0AQ63229792-3B2BB05A-E534-40A6-998B-AB011818BECCQ63399378-0E103C42-9CE6-4A09-A54D-8E2DFD583DA9Q63401497-77359D32-E38D-4326-98F2-0CBE7BE53C17Q63534421-C0162A28-A20B-4491-85E2-49C442B2368CQ63570808-AE7705DC-7077-4408-A531-EB9D9AFD1B1DQ63574272-E3EB6A6C-CA71-4C01-BA5D-BEA65A68B55EQ63574281-BC1840A9-A138-43D5-8BB2-872BC9F22A52Q63576217-F7D21EC2-4CCD-4C87-8B25-6538BECF0DA7Q63577596-5217CFBE-E52F-4C90-9E26-CBE46C284D24Q63577795-A15C73BC-C191-41EB-81E7-6286688F2CBCQ63588139-9C96785B-3CB3-4491-86DF-A9B324BFD7C4Q63811521-07AE68CA-8026-4654-B3D8-DE5BF108B78EQ86257887-0335B0AE-7563-4DE0-885E-6CC6FC46A4D4Q87932857-53A5BAD0-DEFC-41F8-A534-CE4CF52A9E96
P4844
description
chemická sloučenina
@cs
chemische Verbindung
@de
chemische verbinding
@nl
component quimic
@oc
compost químic
@ca
composto chimico
@it
composto químico
@gl
composto químico
@pt
composto químico
@pt-br
composé chimique
@fr
name
Alpharadin
@de
Alpharadin
@nb
Radijum-223 hlorid
@sh
Radijum-223 hlorid
@sr
radium 223
@fr
radium ra-223 dichloride
@en
רדיום-223 כלוריד
@he
type
label
Alpharadin
@de
Alpharadin
@nb
Radijum-223 hlorid
@sh
Radijum-223 hlorid
@sr
radium 223
@fr
radium ra-223 dichloride
@en
רדיום-223 כלוריד
@he
altLabel
RADIUM CHLORIDE RA-223
@en
Radium Ra 223 Dichloride
@en
Radium Ra-223 dichloride
@en
Radium-223 chloride
@en
Radium-223 dichloride
@en
alpharadin
@en
bay-88-8223
@en
bay88-8223
@en
radium chloride (223racl2)
@en
radium chloride ra-223
@en
prefLabel
Alpharadin
@de
Alpharadin
@nb
Radijum-223 hlorid
@sh
Radijum-223 hlorid
@sr
radium 223
@fr
radium ra-223 dichloride
@en
רדיום-223 כלוריד
@he
P592
P646
P661
P683
P1748
P186
P2017
[Cl-].[Cl-].[223Ra+2]
P2175
P231
444811-40-9
P233
[Cl-].[Cl-].[Ra+2]
P234
1S/2ClH.Ra/h2*1H;/q;;+2/p-2/i;;1-3
P235
RWRDJVNMSZYMDV-SIUYXFDKSA-L
P267
P3117
DTXSID80893194
P3345
P3780
P592
CHEMBL2107816
P646
/m/05zk4qx
P652
RJ00KV3VTG